Clover Health Investments, Corp. Class A

Stage 2 · Advancing · week 2

As of Oct 22, 2026, Clover Health Investments is in Stage 2, the uptrend phase, now in week 2 (since Oct 14, 2026). It closed at $4.73, 12.6% below its 52-week high and above its 200-day average, which is rising.

Clover Health Investments, Corp. provides medicare advantage plans in the United States. More about the company

$4.73

-0.20% today

$2.5B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

Early entry: still early enough in its move

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 5 in Healthcare Plans · #1 of 272 in Health Care

Is CLOV early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 26w

S4 17w

S4 22w

S2 13w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 8w → S3 5w → S4 13w → S1 2w → S4 13w → S1 4w → S2 26w → S3 5w → S2 9w → S3 7w → S4 17w → S1 2w → S4 2w → S1 5w → S4 22w → S1 4w → S2 13w → S3 6w → S2 1w current

Total tracked: 165 weeks across 19 stage runs.

CLOV among Healthcare Plans4th of 11 by relative strength

All 11 →

Stocks in Healthcare Plans ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CNCCentene Corporation	Stage 2 · wk 1	94	+14.8%
2	OSCROscar Health, Inc. Class A	Stage 2 · wk 22	87	+9.1%
3	PGNYProgyny, Inc.	Stage 3 · wk 7	86	+12.7%
4	CLOVClover Health Investments, Corp. Class A	Stage 2 · wk 2	85	+3.5%
5	HUMHumana Inc.	Stage 2 · wk 2	84	+12.3%
6	ELVElevance Health, Inc.	Stage 2 · wk 6	76	+11.7%
7	UNHUnitedHealth Group Incorporated	Stage 3 · wk 7	69	+14.5%
8	CVSCVS Health Corporation	Stage 3 · wk 7	68	+10.8%

vs 52W High

-12.6%

$1.70 lo$5.41 hi

12.6% below 52W high, pullback range

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 2

1w13w26w

Week 2, fresh breakout

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

35.9%

200 DMA: $3.48 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.78x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↗

Short-term trend rising gently

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+3.5%

+9.5%

+97.1%

YTD

+96.3%

+46.9%

Scan Membership

Breakout Watch

Latest: 2025-01-30

4 appearances in last 60 days. First seen: 2021-08-03.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 2 · Vol 0.78x

2026-10-21S2

Wk 2 · Vol 0.70x

2026-10-20S2

Wk 1 · Vol 0.84x

2026-10-19S2

Wk 1 · Vol 0.90x

2026-10-16S2

Wk 1 · Vol 0.85x

2026-10-15S2

Wk 1 · Vol 0.76x

2026-10-14S23→2

Wk 1 · Vol 0.85x

2026-10-13S3

Wk 6 · Vol 0.86x

2026-10-12S3

Wk 6 · Vol 0.88x

2026-10-09S3

Wk 6 · Vol 2.49x

2026-10-08S3

Wk 5 · Vol 1.30x

2026-10-07S3

Wk 5 · Vol 1.78x

Moving averages & range

50 DMA

$4.47

200 DMA

$3.48

52W High

$5.41

52W Low

$1.70

5D Low

$4.44

Resistance levels (recent highs)

20d High

$4.81

60d High

$5.10

120d High

$5.41

250d High

$5.41

Next resistance

+1.7%

to 20d High

ROE

-5.1%

Profit margin -0.7%

Dividend Yield

0.00%

P/B 6.7

Clover Health Investments: quick answers

What stage is Clover Health Investments in?

As of Oct 22, 2026, Clover Health Investments (CLOV) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 14, 2026 and is in week 2. What the four stages mean

Is Clover Health Investments in an uptrend?

Yes. Clover Health Investments is in a Stage 2 uptrend. It trades 35.9% above its 200-day average, which is rising.

How far is Clover Health Investments from its 52-week high?

Clover Health Investments closed at $4.73 on Oct 22, 2026, 12.6% below its 52-week high of $5.41. Its 52-week low is $1.70.

How has Clover Health Investments performed over the past year?

As of Oct 22, 2026, Clover Health Investments is up 46.9% over the past year and up 96.3% so far in 2026.

Which sector and industry is Clover Health Investments in?

Clover Health Investments is in the Healthcare Plans industry, part of the Health Care sector.

About this companyHealth Care· Healthcare Plans

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.